Alterations in Serum Vanillylmandelic Acid Levels in patients With Hypertension: A Case-Control Study
Journal of Progressive Medical Sciences · 2026
DOI: 10.63939/j8gqak63 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Journal of Progressive Medical Sciences, 2026. Verfasst von Hussein Bahaa Abd Alrzaaq und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The metabolic abnormalities and sympathetic activity are linked to hypertension. Catecholamine metabolism can be inferred indirectly from vanillylmandelic acid (VMA), which is the last metabolite of norepinephrine and epinephrine. However, it is unclear how serum VMA levels relate to antihypertensive medication, age, body weight, and hyperlipidemia in hypertensive individuals.
Aim
The purpose of this study was to evaluate the connection between serum VMA levels and hyperlipidemia, age, body mass index, and antihypertensive medication in men with hypertension and healthy controls.
Methods
Ninety men between the ages of thirty and fifty-nine were recruited from Al-Sader Teaching Hospital in Najaf to participate in case-control research. Of them, sixty had hypertension and thirty appeared healthy. The presence or absence of hyperlipidemia, treatment status (newly diagnosed or on antihypertensive medication), and body mass index were used to further categorize the hypertensive subjects. ELISA was used to measure the levels of serum VMA. The t-test and one-way analysis of variance (ANOVA) were used to compare groups; p < 0.05 was deemed statistically significant.
Results
Compared to healthy controls, hypertension patients had considerably higher serum VMA levels (p < 0.0001). VMA concentrations were highest in hypertensive patients who also had hyperlipidemia, and they increased with age. VMA levels were higher in newly diagnosed individuals than in those on antihypertensive medication. Furthermore, serum VMA levels rose gradually in all BMI groups, with obese individuals showing the highest levels.
Conclusions
Increased sympathetic activity and altered catecholamine metabolism may be the cause of elevated blood VMA levels in hypertensive men, especially those with hyperlipidemia, obesity, advanced age, and recently diagnosed hypertension. More longitudinal investigations are required to confirm the clinical importance of serum VMA as a possible measure of cardiometabolic risk in hypertension.
Zitieren
APA
Alrzaaq, H. B. A., Abdulwahid, A. A., & Al-khalidi, Z. S. (2026). Alterations in Serum Vanillylmandelic Acid Levels in patients With Hypertension: A Case-Control Study. Journal of Progressive Medical Sciences. https://doi.org/10.63939/j8gqak63
Vancouver
Alrzaaq HBA, Abdulwahid AA, Al-khalidi ZS. Alterations in Serum Vanillylmandelic Acid Levels in patients With Hypertension: A Case-Control Study. Journal of Progressive Medical Sciences. 2026. doi:10.63939/j8gqak63
BibTeX
@article{Alrzaaq2026,
author = {Alrzaaq, Hussein Bahaa Abd and Abdulwahid, Ali Abdulhasan and Al-khalidi, Zainab sabah},
title = {Alterations in Serum Vanillylmandelic Acid Levels in patients With Hypertension: A Case-Control Study},
journal = {Journal of Progressive Medical Sciences},
year = {2026},
doi = {10.63939/j8gqak63}
}
EUVIMED